US equities |
NVDA $240.16 ▲+0.53% SPCX $172.35 ▲+0.74% MU $1,059.56 ▼-0.41% MRVL $288.18 ▲+6.24% AMD $653.65 ▲+3.47% INTC $114.67 ▼-1.31% AVGO $377.98 ▲+4.27% TSLA $380.23 ▲+0.40%
FinancialContent

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

29.24 -0.43 (-1.45%)
Delayed Quote Updated: 2:30 PM EDT, Oct 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2
...
27 28 29 30 31 32 33 34 35
...
61 62 Next >
News headline image
Shareholder Alert: Robbins LLP Informs Investors of the Hims & Hers Health, Inc. Class Action
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
News headline image
Shareholder Alert: Robbins LLP Informs Investors of the Hims &amp; Hers Health, Inc. Class Action
Via TheNewswire.com
News headline image
2 Volatile Stocks Worth Your Attention and 1 to Turn Down
A highly volatile stock can deliver big gains - or just as easily wipe out a portfolio if things go south. While some investors embrace risk, mistakes can be costly for those who aren’t prepared. 
Via StockStory
News headline image
This Weight Loss Partnership Was a Short One ↗
Via The Motley Fool
Topics Economy
News headline image
After Its Biggest Drop Ever...Is HIMS A Buy? ↗
 
Via Benzinga
News headline image
Hims & Hers Health, Inc. (NYSE: HIMS) Accused of “Illegal Mass Compounding and Deceptive Marketing” Practices; Investors Urged to Contact Award-Winning Firm, Gibbs Mura
From Gibbs Mura
Via Business Wire
News headline image
Kaplan Fox Alerts Investors of Hims & Hers Health, Inc. (HIMS) to a Securities Class Action Deadline on August 25, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
Kaplan Fox Alerts Investors of Hims &amp; Hers Health, Inc. (HIMS) to a Securities Class Action Deadline on August 25, 2025
Via TheNewswire.com
Topics Lawsuit
News headline image
Why Is Hims & Hers Health (HIMS) Stock Soaring Today
Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 12.1% in the afternoon session after the company's CEO stated that it will continue to offer cheaper, compounded versions of GLP-1... 
Via StockStory
Topics Artificial Intelligence
News headline image
HIMS & HERS HEALTH SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Hims & Hers Health, Inc. - HIMS
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
HIMS BREAKING NEWS: A Class Action Lawsuit has been filed against Hims & Hers Health, Inc. -- Investors are Notified to Contact BFA Law to Potentially Recover Investment Losses
From Bleichmar Fonti & Auld LLP
Via Business Wire
News headline image
What's Going On With Hims & Hers Health Stock Today? ↗
Hims & Hers Health Inc. (NYSE: HIMS) shares are trading higher Thursday. The stock appears to be bouncing back a bit after selling off to start the week. Here's a look at what you need to know. 
Via Benzinga
News headline image
Behind the Scenes of Hims & Hers Health's Latest Options Trends ↗
 
Via Benzinga
News headline image
HIMS SECURITIES NOTICE: Hims & Hers Health, Inc. Investors May Have Been Affected by Fraud - Contact BFA Law if You Suffered Losses
Via ACCESS Newswire
News headline image
Law Offices of Howard G. Smith Encourages Hims & Hers Health, Inc. (HIMS) Investors To Inquire About Securities Fraud Class Action
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
NYSE: HIMS: Kessler Topaz Meltzer & Check, LLP Announces the Filing of a Securities Class Action Lawsuit Against Hims & Hers Health, Inc. (HIMS)
From Kessler Topaz Meltzer & Check, LLP
Via Business Wire
News headline image
HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
News headline image
Law Offices of Frank R. Cruz Encourages Hims & Hers Health, Inc. (HIMS) Investors To Inquire About Securities Fraud Class Action
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
Rosen Law Firm Urges Hims & Hers Health, Inc. (NYSE: HIMS) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
From The Rosen Law Firm, P.A.
Via Business Wire
News headline image
HIMS & HERS HEALTH, INC. (NYSE: HIMS) INVESTOR ALERT: Investors With Large Losses in Hims & Hers Health, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights
From Bernstein Liebhard LLP
Via GlobeNewswire
News headline image
Why Hims & Hers Stock Is Crashing, and Is It a Buying Opportunity? ↗
Via The Motley Fool
News headline image
HIMS CLASS ACTION NOTICE: The Law Offices of Frank R. Cruz Files Securities Fraud Lawsuit Against Hims & Hers Health, Inc.
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
HIMS CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit on Behalf of Hims & Hers Health, Inc. Investors
From Glancy Prongay & Murray LLP
Via Business Wire
News headline image
4 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Hims & Hers Health, Inc. - HIMS
Via ACCESS Newswire
News headline image
HIMS Investors Have Opportunity to Join Hims & Hers Health, Inc. Fraud Investigation with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
BFA Law Notifies Hims & Hers Health, Inc. (HIMS) Investors that the Company is being Investigated for Securities Fraud - Contact the Firm if You Lost Money
Via ACCESS Newswire
News headline image
HIMS & HERS HEALTH INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates Claims on Behalf of Investors of Hims & Hers Health, Inc. - HIMS
From Kahn Swick & Foti, LLC
Via GlobeNewswire
News headline image
Hims & Hers CEO Says 'No Way In Hell We're Gonna Cave On' Selling Compounded Obesity Drugs After Novo Nordisk Breakup ↗
Truist warned that Hims faces renewed litigation risk after Novo's exit, which could create a prolonged legal overhang on the stock. 
Via Stocktwits
Topics Law Enforcement Lawsuit
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Hims & Hers Health, Inc. - HIMS
Via ACCESS Newswire
< Previous 1 2
...
27 28 29 30 31 32 33 34 35
...
61 62 Next >